← Eichor
Study identifier: NCT06787183 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Condition: Locally Advanced Rectal Cancer With Liver Metastases  ·  Sponsor: Fujian Cancer Hospital

PhasePhase 2
Planned participants42
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

To enhance the treatment efficacy of rectal cancer liver metastasis through a multidisciplinary approach of radiotherapy, immunotherapy, and chemotherapy, and to provide a new direction for the combination treatment strategy.

This description comes directly from the study's public registry record.

Talk to the study team

Hui Li, MD  ·  +8613600855801  ·  lihui70105@126.com

Jinluan Li, MD  ·  +86 15159628678  ·  lijinluan@fjmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Fuzhou First General HospitalFuzhou, Fujian, ChinaNot Yet Recruiting
Fujian Cancer HospitalFuzhou, Fujian, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06787183